Given its central role in many cellular processes, dysregulation of cAMP signaling is implicated in various diseases, including cancer, heart disease, and diabetes. Therapeutic agents targeting cAMP pathways are being developed to treat these conditions. For instance, phosphodiesterase inhibitors are used to prevent the degradation of cAMP, thereby enhancing its signaling effects.
